Cost-effectiveness of population-based screening for diabetes and hypertension in India: an economic modelling study-Reference-Cited by-同舟云学术

Cost-effectiveness of population-based screening for diabetes and hypertension in India: an economic modelling study

Published:2022-01 Issue:1 Volume:7 Page:e65-e73
ISSN:2468-2667
Container-title:The Lancet Public Health
language:en
Short-container-title:The Lancet Public Health

Author:

Kaur Gunjeet,Chauhan Akashdeep Singh,Prinja Shankar,Teerawattananon Yot,Muniyandi Malaisamy,Rastogi Ashu,Jyani Gaurav,Nagarajan Karikalan,Lakshmi PVM,Gupta Ankur,Selvam Jerard M,Bhansali Anil,Jain Sanjay

Funder

Department of Health Research, India

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health

Reference44 articles.

1. Training module for medical officers for prevention, control and population level screening of hypertension, diabetes and common cancer (oral, breast & cervical),2017

2. Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis;Kahn;Lancet,2010

3. Is diabetes and hypertension screening worthwhile in resource-limited settings? An economic evaluation based on a pilot of a Package of essential non-communicable disease interventions in Bhutan;Dukpa;Health Policy Plan,2015

4. One step back, two steps forward: an economic evaluation of the PEN program in Indonesia;Rattanavipapong;Health Syst Reform,2016

5. Cost-effectiveness of a national population-based screening program for type 2 diabetes: the Brazil experience;Toscano;Diabetol Metab Syndr,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing diabetes surveillance ecosystems: a case study of India;The Lancet Diabetes & Endocrinology;2024-07

2. Exploring the Potential of Traditional Herbal Plants in the Management of Diabetes Mellitus: A Comprehensive Investigation;Journal of Natural Remedies;2024-05-28

3. Economic Evaluation of Hypertension screening in Iran using Markov model;2024-04-26

4. Does Price Really Matter for Generic Alternatives? Supervised learning Approaches in Deciding the Right Price for Acceptable Quality Attributes of Amlodipine Besylate among Generic Alternatives;Indian Journal of Public Health;2024-04

5. Cost-Effectiveness of Routine Monitoring of Long-Term Conditions in Primary Care: Informing Decision Modelling with a Systematic Review in Hypertension, Type 2 Diabetes and Chronic Kidney Disease;PharmacoEconomics - Open;2024-02-23